Erbitux Study of CPT11, Oxaliplatin, UFToral Targeted Therapy

NCT01225744 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

47

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Colorectal Cancer

Interventions

DRUG: Cetuximab
DRUG: Irinotecan
DRUG: Oxaliplatin
DRUG: UFT

Sponsor

The Christie NHS Foundation Trust

Collaborators

[object Object]